Document is current
Any future updates will be listed below
-
Authors
Jangda, Mateen
Patel, Jayshil
Vaid, Akhil https://orcid.org/0000-0002-3343-744X
Gill, Jaskirat
McCarthy, Paul
Desman, Jacob https://orcid.org/0000-0002-5411-6637
Gupta, Rohit
Patel, Dhruv
Kavi, Nidhi
Bakare, Shruti
Klang, Eyal https://orcid.org/0000-0002-4567-3108
Freeman, Robert
Manasia, Anthony
Oropello, John https://orcid.org/0000-0003-4467-3584
Chan, Lili
Suarez-Farinas, Mayte https://orcid.org/0000-0001-8712-3553
Charney, Alexander W. https://orcid.org/0000-0001-8135-6858
Kohli-Seth, Roopa
Nadkarni, Girish N. https://orcid.org/0000-0001-6319-4314
Sakhuja, Ankit https://orcid.org/0000-0002-2045-518X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K08DK131286)
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 1 November 2025
First Online: 17 December 2025
Competing interests
: The authors declare the following competing interests: GNN is a founder of Renalytix, Pensieve, Verici and provides consultancy services to AstraZeneca, Reata, Renalytix, Siemens Healthineer and Variant Bio, serves a scientific advisory board member for Renalytix and Pensieve. He also has equity in Renalytix, Pensieve and Verici. LC is a consultant for Vifor Pharma INC and has received honorarium from Fresenius Medical Care. All other authors declare no competing interests.
